IMNN
Price
$0.42
Change
+$0.02 (+5.00%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
6.47M
83 days until earnings call
PHIO
Price
$1.84
Change
+$0.05 (+2.79%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
8.55M
Interact to see
Advertisement

IMNN vs PHIO

Header iconIMNN vs PHIO Comparison
Open Charts IMNN vs PHIOBanner chart's image
Imunon
Price$0.42
Change+$0.02 (+5.00%)
Volume$10.44K
Capitalization6.47M
Phio Pharmaceuticals
Price$1.84
Change+$0.05 (+2.79%)
Volume$907
Capitalization8.55M
IMNN vs PHIO Comparison Chart
Loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNN vs. PHIO commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNN is a Buy and PHIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (IMNN: $0.40 vs. PHIO: $1.79)
Brand notoriety: IMNN and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNN: 169% vs. PHIO: 3%
Market capitalization -- IMNN: $6.47M vs. PHIO: $8.55M
IMNN [@Biotechnology] is valued at $6.47M. PHIO’s [@Biotechnology] market capitalization is $8.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNN’s FA Score shows that 0 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • IMNN’s FA Score: 0 green, 5 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, PHIO is a better buy in the long-term than IMNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNN’s TA Score shows that 3 TA indicator(s) are bullish while PHIO’s TA Score has 3 bullish TA indicator(s).

  • IMNN’s TA Score: 3 bullish, 3 bearish.
  • PHIO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IMNN is a better buy in the short-term than PHIO.

Price Growth

IMNN (@Biotechnology) experienced а -34.87% price change this week, while PHIO (@Biotechnology) price change was -3.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

IMNN is expected to report earnings on Aug 13, 2025.

PHIO is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHIO($8.55M) has a higher market cap than IMNN($6.47M). PHIO YTD gains are higher at: -0.556 vs. IMNN (-57.979). PHIO has higher annual earnings (EBITDA): -7.41M vs. IMNN (-17.9M). IMNN has more cash in the bank: 5.87M vs. PHIO (5.39M). PHIO has less debt than IMNN: PHIO (0) vs IMNN (1.14M). IMNN (0) and PHIO (0) have equivalent revenues.
IMNNPHIOIMNN / PHIO
Capitalization6.47M8.55M76%
EBITDA-17.9M-7.41M242%
Gain YTD-57.979-0.55610,436%
P/E RatioN/A0.01-
Revenue00-
Total Cash5.87M5.39M109%
Total Debt1.14M0-
FUNDAMENTALS RATINGS
IMNN vs PHIO: Fundamental Ratings
IMNN
PHIO
OUTLOOK RATING
1..100
5083
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9665
P/E GROWTH RATING
1..100
10062
SEASONALITY SCORE
1..100
8526

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHIO's Valuation (59) in the Biotechnology industry is in the same range as IMNN (74) in the Medical Specialties industry. This means that PHIO’s stock grew similarly to IMNN’s over the last 12 months.

PHIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that PHIO’s stock grew similarly to IMNN’s over the last 12 months.

PHIO's SMR Rating (100) in the Biotechnology industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that PHIO’s stock grew similarly to IMNN’s over the last 12 months.

PHIO's Price Growth Rating (65) in the Biotechnology industry is in the same range as IMNN (96) in the Medical Specialties industry. This means that PHIO’s stock grew similarly to IMNN’s over the last 12 months.

PHIO's P/E Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for IMNN (100) in the Medical Specialties industry. This means that PHIO’s stock grew somewhat faster than IMNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMNNPHIO
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSQH2.040.10
+5.15%
PSQ Holdings
YEXT6.69-0.17
-2.48%
Yext
NDSN196.47-5.93
-2.93%
Nordson Corp
AX69.34-2.57
-3.57%
Axos Financial
UPC5.58-0.45
-7.46%
Universe Pharmaceuticals Inc

IMNN and

Correlation & Price change

A.I.dvisor tells us that IMNN and PCSA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMNN and PCSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
-9.79%
PCSA - IMNN
31%
Poorly correlated
-5.00%
STOK - IMNN
30%
Poorly correlated
-5.67%
DNLI - IMNN
30%
Poorly correlated
-4.20%
DTIL - IMNN
29%
Poorly correlated
-4.71%
IVVD - IMNN
28%
Poorly correlated
-5.52%
More

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-2.19%
MTNB - PHIO
50%
Loosely correlated
+1.30%
TPST - PHIO
49%
Loosely correlated
-6.04%
SAGE - PHIO
41%
Loosely correlated
-4.63%
BPMC - PHIO
40%
Loosely correlated
-1.45%
IMNN - PHIO
39%
Loosely correlated
-9.79%
More